U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Reasy Farms - 01/20/2017
  1. Warning Letters

CLOSEOUT LETTER

Reasy Farms


Recipient:
Reasy Farms

United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

 

 
PHILADELPHIA DISTRICT
U.S. CUSTOMHOUSE
2ND AND CHESTNUT STREETS
ROOM 900
PHILADELPHIA, PA 19106
TELEPHONE: 215-597-4390 

CERTIFIED MAIL
RETURN RECEIPT REQUESTED

January 20, 2017
 

Mr. Chris A. Reasy, Owner/Operator
Reasy Farms
869 Kings Road
New Enterprise, Pennsylvania 16664
 

Dear Mr. Reasy:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 16-PHI-01 issued January 5, 2016. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Steven L. Carter
Director, Compliance Branch
Philadelphia District Office

 
Back to Top